{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T08:30:42Z","timestamp":1697617842193},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1488,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1365-2265.2011.04089.x","type":"journal-article","created":{"date-parts":[[2011,4,30]],"date-time":"2011-04-30T12:02:27Z","timestamp":1304164947000},"page":"395-401","source":"Crossref","is-referenced-by-count":8,"title":["Thyroid status in a large cohort of patients with mental retardation: the TOP-R (Thyroid Origin of Psychomotor Retardation) study"],"prefix":"10.1111","volume":"75","author":[{"given":"Willem Edward","family":"Visser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda B.","family":"de Rijke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"van Toor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo J.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,8,5]]},"reference":[{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1210\/er.18.4.462","article-title":"Molecular basis of thyroid hormone-dependent brain development","volume":"18","author":"Oppenheimer","year":"1997","journal-title":"Endocrine Reviews"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1210\/jc.85.11.3975","article-title":"Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia?","volume":"85","author":"Morreale de Escobar","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jc.82.4.1081","article-title":"Deoxyribonucleic acid binding and transcriptional silencing by a truncated c-erbA beta 1 thyroid hormone receptor identified in a severely retarded patient with resistance to thyroid hormone","volume":"82","author":"Behr","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(04)17226-7","article-title":"Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation","volume":"364","author":"Friesema","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1086\/380999","article-title":"A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene","volume":"74","author":"Dumitrescu","year":"2004","journal-title":"American Journal of Human Genetics"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Archives of Internal Medicine"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jc.87.2.489","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1445-5994.2007.01367.x","article-title":"Prevalence of thyroid disease in an older Australian population","volume":"37","author":"Empson","year":"2007","journal-title":"Internal Medicine Journal"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1352\/0895-8017(2005)110<48:POEIAW>2.0.CO;2","article-title":"Prevalence of epilepsy in adults with mental retardation and related disabilities in primary care","volume":"110","author":"McDermott","year":"2005","journal-title":"American Journal of Mental Retardation"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2265.1978.tb01493.x","article-title":"Thyroid function tests in patients on long-term treatment with various anticonvulsant drugs","volume":"8","author":"Liewendahl","year":"1978","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/00365518009095594","article-title":"Effect of anticonvulsant and antidepressant drugs on iodothyronines in serum","volume":"40","author":"Liewendahl","year":"1980","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3109\/00365517809104880","article-title":"Effect of carbamazepine, phenytoin and phenobarbitone on serum levels of thyroid hormones and thyrotropin in humans","volume":"38","author":"Rootwelt","year":"1978","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.0013-9580.2004.26003.x","article-title":"Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication","volume":"45","author":"Vainionpaa","year":"2004","journal-title":"Epilepsia"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1530\/EJE-08-0325","article-title":"Thyroid hormones in children with epilepsy during long-term administration of carbamazepine and valproate","volume":"160","author":"Verrotti","year":"2009","journal-title":"European Journal of Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jpeds.2007.02.046","article-title":"Risk factors for development of subclinical hypothyroidism during valproic acid therapy","volume":"151","author":"Mikati","year":"2007","journal-title":"Journal of Pediatrics"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yebeh.2009.07.014","article-title":"Reversible effects of antiepileptic drugs on thyroid hormones in men and women with epilepsy: a prospective randomized double-blind withdrawal study","volume":"16","author":"Lossius","year":"2009","journal-title":"Epilepsy & Behavior"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jama.275.19.1495","article-title":"Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine. A paradox resolved","volume":"275","author":"Surks","year":"1996","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pediatrneurol.2007.07.003","article-title":"Evolution of subclinical hypothyroidism in children treated with antiepileptic drugs","volume":"37","author":"Castro-Gago","year":"2007","journal-title":"Pediatric Neurology"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1528-1157.1992.tb02297.x","article-title":"Thyroid function with antiepileptic drugs","volume":"33","author":"Isojarvi","year":"1992","journal-title":"Epilepsia"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/WNF.0b013e318166cbcd","article-title":"Thyroid function in children with epilepsy treated with sodium valproate monotherapy: a prospective study","volume":"32","author":"Attilakos","year":"2009","journal-title":"Clinical Neuropharmacology"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00558149","article-title":"Thyroid hormone concentrations in epileptic patients","volume":"36","author":"Larkin","year":"1989","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000120309","article-title":"Thyroid function in children with long-term anticonvulsant treatment","volume":"13","author":"Tanaka","year":"1987","journal-title":"Pediatric Neuroscience"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2265.2005.02424.x","article-title":"Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study","volume":"64","author":"O\u2019 Leary","year":"2006","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1111\/j.1365-2265.2011.04089.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jc.87.3.1068","article-title":"Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease","volume":"87","author":"Andersen","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2011.04089.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2265.2011.04089.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T11:13:49Z","timestamp":1637579629000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2011.04089.x"}},"subtitle":["Thyroid parameters in the TOP-R study"],"short-title":[],"issued":{"date-parts":[[2011,8,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04089.x","relation":{},"ISSN":["0300-0664"],"issn-type":[{"value":"0300-0664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,5]]}}}